Bill

Bill > H1274


MA H1274

MA H1274
Prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program


summary

Introduced
02/27/2025
In Committee
02/27/2025
Crossed Over
Passed
Dead

Introduced Session

194th General Court

Bill Summary

For legislation to prohibit discrimination against 340B drug discount program participants. Financial Services.

AI Summary

This bill aims to prevent Pharmacy Benefit Managers (PBMs) from discriminating against hospitals and pharmacies participating in the 340B drug discount program, which is a federal program that allows certain healthcare providers to purchase outpatient drugs at significantly reduced prices. Specifically, the bill prohibits PBMs from engaging in several potentially unfair practices, including: reimbursing 340B covered entities at lower rates compared to non-340B entities, imposing additional fees or charge-backs based on 340B program participation, restricting network participation because of 340B status, mandating specific pharmacy contracts, requiring special drug claim modifiers (except for Medicaid claims), imposing additional cost burdens or coverage limitations on patients obtaining drugs from 340B entities, and interfering with patients' rights to choose 340B pharmacies. A "340B covered entity" is defined as any healthcare provider participating in the federal 340B drug discount program, including the entity's own pharmacies or contracted pharmacies that dispense drugs purchased through the program. The bill's purpose is to ensure fair treatment and maintain patient choice in accessing discounted medications through the 340B program.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Accompanied a new draft, see H4494 (on 09/18/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://malegislature.gov/Bills/194/H1274
BillText https://malegislature.gov/Bills/194/H1274.pdf
Loading...